Success Story: Dual NIW & EB1A Success Despite RFE! Our Expert Team Helped A Postdoctoral Fellow Get Approval

“Thanks again to the team who have helped and assisted along the way!”

Case Summary:      

We are excited to announce the approvals of both the I-140 National Interest Waiver (NIW) and the I-140 EB1A (Extraordinary Ability) petitions for our client, a distinguished expert in the field of molecular and cellular pathology. The NIW petition was approved in August 2024, followed by the EB1A approval in September 2025 after responding to a Request for Evidence (RFE).

Driving Advances in Molecular and Cellular Pathology

With a Ph.D. in cellular and molecular pathology, the Client has established himself as one of the few leading specialists in epigenome editing and profiling, vascular calcification, and reproductive toxicology. His proposed endeavor focuses on advancing understanding of the role of vascular smooth muscle cells in cardiovascular disorders, with far-reaching applications for improving public health outcomes.

The Client has authored 16 peer-reviewed journal articles (2 first-authored) and 6 abstracts (2 first-authored) in top-ranked venues, reflecting the quality and originality of his work. His research has been cited 477 times by independent scholars worldwide, further highlighting its influence and widespread adoption across the global scientific community.

Recognition Through Peer Review and Service

To demonstrate the Client’s standing as a trusted authority in his field, we emphasized his active role in shaping the scientific record. He has conducted at least 42 reviews for leading journals, a responsibility entrusted only to top experts. This service underscores both his expertise and his influence in guiding cutting-edge research.

Support and Independent Validation

The petition was further strengthened by four strong recommendation letters from internationally recognized experts in the field, including independent scholars who have cited and relied on the Client’s findings in their own work. These experts praised the originality of his methods, the significance of his contributions to cardiovascular and reproductive health research, and the transformative potential of his future endeavors.

“As a result of his studies, work as a peer reviewer, and other achievements, I attest to [Client’s] work being of significant value to the nation.”

Funding and Broader Impact

The Client’s research has also been supported by major funding agencies, including the National Institutes of Health (NIH), the American Heart Association (AHA), the National Science Foundation (NSF), the National Institute of Environmental Health Sciences (NIEHS), the National Centers for Translational Research in Reproduction and Infertility (NCTRI), and the National Heart, Lung, and Blood Institute (NHLBI). Such funding highlights the recognized national and global importance of his work.

A Successful Outcome

The approvals of both the NIW and EB1A petitions affirm the Client’s extraordinary record of success and the critical national importance of his work. These achievements are also a reflection of our firm’s expertise in presenting strong, well-documented petitions and, in the case of the EB1A, successfully addressing USCIS’s RFE with compelling evidence.

We are proud to have assisted the Client through this process and to have leveraged our experience to secure these outstanding results. His groundbreaking research in molecular and cellular pathology will continue to benefit the United States by advancing therapeutic strategies for cardiovascular disease, toxicology, and beyond.